PTC Therapeutics Awarded $1.6 Million FDA Orphan Drug Grant To Support An Ongoing Phase 3 Study In Cystic Fibrosis

PTC Therapeutics Awarded $1.6 Million FDA Orphan Drug Grant To Support An Ongoing Phase 3 Study In Cystic Fibrosis Discussione PTC Therapeutics Awarded $1.6 Million FDA Orphan Drug Grant To Support An Ongoing Phase 3 Study In Cystic Fibrosis http://www.fceonline.it/chirurgia/vascolare/89952-therapeutics-awarded-million-orphan.html Mon, 20 May 2013 17:43:41 +0000 JComments